To: jeevacationggmail.com[[email protected]] From: Sent: Fri 6/17/2011 4:47:31 PM thought you might enjoy - hadn't thought of sending you prviously but this is daily media monitoring we get for europe. let me know if you ever want? Europe daily media monitoring June 17, 2011 Europe Deworminq and handwashinq can offer better value than immunisation By Will Crouch. Financial Times June 17, 2011 • Will Crouch is Assistant Director and Head of Research at the Uehiro Centre for Practical Ethics at Oxford University. He writes in response to the Financial Times' article "Donors give vaccine fund $4.3bn boost." • The Financial Times has rightly flagged up the debate about whether this is the best use of their funds because of the high price that GAVI pays for vaccinations, and the problems GAVI faces with implementing its immunization programs. • But it's important that "cost-effectiveness" is properly understood. The UK's Department for International Development refers to "value for money" when describing its priorities. But it doesn't have a sensible metric for what counts as "value." • But health economists do: namely, the Disability Adjusted Life Year, or DALY. This represents one lost year of healthy life: averting one DALY is equivalent in value to giving one person one year of life at very high quality health. • Research using this metric shows that what we should be most concerned about is not whether the GAVI gets a good price for its vaccines, but whether immunization is the right program to fund at all. By funding the rotavirus and pneumococcal vaccines, it is paying $100 for every DALY averted. This is a very good deal compared with many other uses of the money, but surprisingly we can do much better again. Sarkozy targets commodity prices By Staff Financial Times June 16, 2011 • A whole range of commodity markets have spent the last six months flirting with multiyear highs. One reason is the surging demand in em